Wikman, Anna http://orcid.org/0000-0003-0937-0887
Sacher, Julia
Bixo, Marie
Hirschberg, Angelica L.
Kopp Kallner, Helena
Epperson, C. Neill
Comasco, Erika
Sundström Poromaa, Inger
Funding for this research was provided by:
Vetenskapsrådet (2016-01439, 2015-00495, 2020-01801)
Svenska Läkaresällskapet (SLS-573171, SLS-597211, SLS-789101)
EU FP7-People-Cofund (INCA 600398)
Uppsala University
Article History
Received: 25 May 2021
Accepted: 29 January 2022
First Online: 11 February 2022
Declarations
:
: The study was approved by the Regional Ethical Review Board, Sweden (2016/184). Written informed consent was obtained from all participants. No additional administrative permissions were required to access and use the data/medical records included in the study.
: Not applicable.
: ISP has served on advisory boards or acted as invited speaker at scientific meetings for MSD, Bayer Health Care, Gedeon Richter, Peptonics, Shire/Takeda, and Lundbeck A/S. MB is medical advisor for Asarina Pharma. HKK has served on advisory boards for Gedeon Richter and has received honorariums for lectures from Gedeon Richter; has received honorariums for lectures from: Actavis, Bayer, Gedeon Richter Exeltis, Nordic Pharma, Natural Cycles, Mithra, Teva, Merck; has provided expert opinion for: Bayer, Evolan, Gedeon Richter, Exeltis, Merck, Teva, TV4 och Natural Cycles; has thought courses sponsored by: Merck and MSD och Bayer; and has written book chapters sponsored by Bayer. CNE discloses that she serves on the advisory board for Asarina Pharma and consults to Sage Therapeutics. NE discloses that she serves on the advisory boards as a consultant for Sage Therapeutics and Asarina Pharma.